Conclusions Cardiological management of cardiovascular risk factors prior to treatment with fluoropyrimidines resulted in half as many cardiotoxic events but the study did not reach statistical significance .
← all excerpts
Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial.
1
—
—